Pilot phase I study of gefitinib (GEF) in combination with paclitaxel (PAC) and radiation therapy (RT) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) and effects on epidermal growth factor receptor (EGFR) signaling pathway

被引：0
|
作者：
Morris, J. C.
Allen, C.
Citrin, D.
Gius, D.
Chen, Z.
Colevas, A. D.
Harold, N.
Rudy, S.
Singh, A. K.
VanWaes, C.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NIDCD, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16526
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population
    Fernandez-Mateos, J.
    Seijas-Tamayo, R.
    Mesia, R.
    Taberna, M.
    Pastor Borgonon, M.
    Perez-Ruiz, E.
    Klain, J. C. Adansa
    Vazquez Fernandez, S.
    del Barco Morillo, E.
    Lozano, A.
    Gonzalez Sarmiento, R.
    Cruz-Hernandez, J. J.
    ORAL ONCOLOGY, 2016, 63 : 38 - 43
  • [2] Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer
    Chen, Changhu
    Kane, Madeleine
    Song, John
    Campana, John
    Raben, Adam
    Hu, Kenneth
    Harrison, Louis
    Quon, Harry
    Dancey, Janet
    Baron, Anna
    Said, Sherif
    Eckhardt, S. Gail
    Raben, David
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 4880 - 4886
  • [3] Risk of dermatologic toxicity to radiation therapy (RT) plus epidermal growth factor receptor inhibitor (EGFRI) therapy in head and neck squamous cell carcinoma (HNSCC)
    Tejwani, A.
    Wu, S.
    Millender, L. E.
    Agulnik, M.
    Lacouture, M. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S399 - S399
  • [4] Identification of epidermal growth factor receptor (EGFR) polymorphisms that modify risk for squamous cell carcinoma of the head and neck (HNSCC).
    Fung, Christopher
    Trent, Kerry
    Joyce, Sonali
    Zhou, Pei
    Nukui, Tomoko
    Weeks, Daniel E.
    Diergaarde, Brenda
    Ye, Yuanqing
    Wu, Xifeng
    Yuan, Jian-Min
    Grandis, Jennifer
    Weissfeld, Joel L.
    Romkes, Marjorie
    Egloff, Ann Marie
    CANCER RESEARCH, 2013, 73 (08)
  • [5] Paclitaxel in combination with anti-EGFR therapy as induction chemotherapy for patients unfit for cisplatin with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Marin, J. A.
    Oliva Bernal, M.
    Plana Serrahima, M.
    Ferrer, M.
    Vilarino Quintela, N.
    Vazquez, S.
    Vilajosana, E.
    Lozano, A.
    Nogues, J.
    Mari, A.
    Bermejo, O.
    Mesia Nin, R.
    Taberna Sanz, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 383 - 383
  • [6] Phase I evaluation of vandetanib with radiation therapy (RT) ± cisplatin in previously untreated advanced head and neck squamous cell carcinoma (HNSCC)
    Papadimitrakopoulou, V.
    Frank, S. J.
    Blumenschein, G. R.
    Chen, C.
    Kane, M.
    Cohen, E. E.
    Langmuir, P.
    Krebs, A. D.
    Lippman, S. M.
    Raben, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Updated clinical and biomarker results from a phase I study of vandetanib with radiation therapy (RT) with or without cisplatin in locally advanced head and neck squamous cell carcinoma (HNSCC).
    Papadimitrakopoulou, V.
    Heymach, J.
    Frank, S. J.
    Myers, J.
    Lin, H.
    Tran, H. T.
    Chen, C.
    Hirsch, F. R.
    Langmuir, P. B.
    Vasselli, J. R.
    Lippman, S. M.
    Raben, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Harrington, Kevin J.
    El-Hariry, Iman A.
    Holford, Clare S.
    Lusinchi, Antoine
    Nutting, Christopher M.
    Rosine, Dominique
    Tanay, Mary
    Deutsch, Eric
    Matthews, Jennifer
    D'Ambrosio, Consuelo
    Turner, Simon J.
    Pandeshwara, Jagannatha S.
    Bourhis, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1100 - 1107
  • [9] A phase I study of metformin in combination with cisplatin and radiation in locally advanced head and neck squamous cell carcinoma.
    Wise-Draper, Trisha Michel
    Takiar, Vinita
    Mierzwa, Michelle Lynn
    Huth, Bradley Joseph
    Redmond, Kevin P.
    Barrett, William
    Qualtieri, Julianne
    Xie, Changchun
    Morris, John Charles
    Gutkind, J. Silvio
    Sadraei, Nooshin Hashemi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Feasibility study of capecitabine (cap) and cisplatin (cis) with radiation therapy (RT) in the management of patients with locally advanced unresectable squamous cell carcinoma of the head and neck (HNSCC)
    Allen, J. W.
    Vasireddy, S.
    Kaufman, J.
    Hughes, J. M.
    Sebelik, M.
    Salazar, J. E.
    Niell, H. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345